Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

IRLAIRulya Therapeutics Inc.

Nasdaq · CIK 0001662774
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts354

Identity from submissions API

NameIRulya Therapeutics Inc.
CIK0001662774
TickersIRLA
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN901024039
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone203-208-8994
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Quince Therapeutics, Inc. (2022-08-09T00:00:00.000Z → 2026-10-09T00:00:00.000Z)
  • Cortexyme, Inc. (2016-01-05T00:00:00.000Z → 2022-08-01T00:00:00.000Z)
Business address
101 COLLEGE STREET, SUITE 210
NEW HAVEN
CT
06510
CT
Mailing address
101 COLLEGE STREET, SUITE 210
NEW HAVEN
CT
06510
CT

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

475 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-19 S-8 S-8 0001193125-26-468531 333-300160 261574713 33 413283 1 1
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001778253-26-000009 005-91007 261563725 34 164210
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-128354 005-91007 261561392 34 9344
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002050709-26-000035 005-91007 261558409 34 81140
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-005046 005-91007 261555086 34 16441
2026-11-13 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-127344 005-91007 261554785 34 9299
2026-11-13 8-K 8-K 2.02,9.01 0001193125-26-460775 001-38890 261553109 34 210949 1 1
2026-11-13 10-Q 10-Q 0001193125-26-460562 001-38890 261552196 34 17063555 1 1
2026-11-12 4 xslF345X06/form4-11122026_041110.xml 0001930805-26-000006 5867
2026-11-12 4 xslF345X06/form4-11122026_041108.xml 0002159117-26-000004 5938
2026-11-12 4 xslF345X06/form4-11122026_041105.xml 0001233539-26-000005 5871
2026-11-12 4 xslF345X06/form4-11122026_041103.xml 0002159407-26-000004 5940
2026-11-12 4 xslF345X06/form4-11122026_041101.xml 0001662170-26-000004 5681
2026-11-05 144 xsl144X01/primary_doc.xml 0001628280-26-070962 001-38890 261526909 33 9939
2026-10-21 144 xsl144X01/primary_doc.xml 0001628280-26-066751 001-38890 261476614 33 4671
2026-10-19 3 xslF345X06/form3-10192026_081001.xml 0002159407-26-000002 8666
2026-10-19 3 xslF345X06/form3-10192026_081004.xml 0002159117-26-000002 8663
2026-10-19 3 xslF345X06/form3-10192026_081051.xml 0001930805-26-000004 8582
2026-10-19 3 xslF345X06/form3-10192026_081047.xml 0001662170-26-000002 8600
2026-10-19 3 xslF345X06/form3-10192026_081042.xml 0002159394-26-000002 30598
2026-10-19 3 xslF345X06/form3-10192026_081007.xml 0001233539-26-000003 8586
2026-10-19 8-K 8-K 7.01,9.01 0001193125-26-424731 001-38890 261467627 34 3881128 1 1
2026-10-14 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-115859 005-91007 261460334 34 19255
2026-10-14 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-421651 005-91007 261459952 34 12420
2026-10-09 8-K 8-K 5.02,5.03,7.01,8.01,9.01 0001193125-26-418538 001-38890 261451158 34 476031 1 1
2026-10-08 S-8 S-8 0001193125-26-418091 333-299377 261450606 33 424768 1 1
2026-10-06 8-K 8-K 5.02,5.03,5.07,9.01 0001193125-26-415730 001-38890 261444741 34 567687 1 1
2026-10-02 DEFA14A DEFA14A 0001193125-26-411262 001-38890 261433423 34 33225
2026-10-02 8-K 8-K 5.02 0001193125-26-411260 001-38890 261433420 34 162361 1 1
2026-09-14 8-K 8-K 2.01,5.02,9.01 0001193125-26-390652 001-38890 261377726 34 677882 1 1
2026-09-04 8-K 8-K 3.01 0001193125-26-382838 001-38890 261360209 34 140102 1 1
2026-08-27 8-K 8-K 5.02 0001193125-26-371389 001-38890 261331026 34 137278 1 1
2026-08-25 DEF 14A DEF 14A 0001193125-26-364220 001-38890 261312445 34 4657735 1 1
2026-08-24 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002741 333-297903 261312280 33 1863
2026-08-17 8-K 8-K 8.01,9.01 0001193125-26-353141 001-38890 261284622 34 202739 1 1
2026-08-14 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-352966 005-91007 261284480 34 154523
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-097291 005-91007 261283052 34 10981
2026-08-14 10-Q 10-Q 0001193125-26-352201 001-38890 261281284 34 16885851 1 1
2026-08-14 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-003692 005-91007 261279707 34 12023
2026-08-14 8-K 8-K 2.02,9.01 0001193125-26-350568 001-38890 261276336 34 209918 1 1
2026-08-14 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-003433 005-91007 261275842 34 16382
2026-08-05 S-3/A S-3/A 0001193125-26-333764 333-297903 261241191 33 78438
2026-08-04 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002050709-26-000021 005-91007 261237864 34 80814
2026-07-31 8-K 8-K 5.02 0001193125-26-328784 001-38890 261229251 34 152473 1 1
2026-07-31 PRE 14A PRE 14A 0001193125-26-328777 001-38890 261229239 34 4957670 1 1
2026-07-31 S-3 S-3 0001193125-26-328769 333-297903 261229219 33 719098 1 1
2026-07-30 8-K/A 8-K/A 8.01,9.01 0001193125-26-324786 001-38890 261219948 34 2530048 1 1
2026-06-26 8-K/A 8-K/A 3.03 0001193125-26-285572 001-38890 261129865 34 147496 1 1
2026-06-26 8-K 8-K 3.03,5.03,9.01 0001193125-26-284089 001-38890 261124176 34 158020 1 1
2026-06-15 4 FORM 4 0000912282-26-000832 5438
2026-06-15 4 FORM 4 0000912282-26-000830 5456
2026-06-11 4 xslF345X06/form4-06112026_090603.xml 0001346566-26-000004 25538
2026-06-11 3 xslF345X06/form3-06112026_090601.xml 0001346566-26-000003 11091
2026-06-11 8-K 8-K 5.07 0001193125-26-267862 001-38890 261084028 34 151879 1 1
2026-06-11 D xslFormDX01/primary_doc.xml 06b 0000912282-26-000811 021-587011 261082204 33 11544
2026-06-11 D xslFormDX01/primary_doc.xml 06b 0000912282-26-000809 021-587010 261082203 33 11354
2026-06-10 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-072388 005-91007 261080253 34 20092
2026-05-21 8-K 8-K 8.01 0001193125-26-234858 001-38890 261009765 34 137835 1 1
2026-05-18 8-K/A 8-K/A 7.01,9.01 0001193125-26-228956 001-38890 26993645 34 182695 1 1
2026-05-18 8-K 8-K 1.01,2.01,3.02,5.02,5.03,7.01,9.01 0001193125-26-228133 001-38890 26991089 34 6136170 1 1
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-062688 005-91007 26988871 34 11172
2026-05-11 10-Q 10-Q 0001193125-26-217098 001-38890 26964399 34 11938607 1 1
2026-04-28 8-K 8-K 8.01 0001193125-26-187243 001-38890 26908356 34 138654 1 1
2026-04-27 ARS ARS 0001193125-26-182282 001-38890 26901671 34 1241213
2026-04-27 DEFA14A DEFA14A 0001193125-26-182267 001-38890 26901652 34 933263 1 1
2026-04-27 DEF 14A DEF 14A 0001193125-26-182255 001-38890 26901638 34 5621139 1 1
2026-04-22 8-K 8-K 5.02 0001193125-26-170572 001-38890 26884223 34 139991 1 1
2026-04-17 PRE 14A PRE 14A 0001193125-26-161838 001-38890 26872718 34 5392976 1 1
2026-04-17 S-8 S-8 0001193125-26-161725 333-295164 26872365 33 199555 1 1
2026-04-10 10-K 10-K 0001193125-26-151364 001-38890 26855392 34 16792188 1 1
2026-04-09 8-K 8-K 3.03,5.03,9.01 0001193125-26-149021 001-38890 26850028 34 158123 1 1
2026-04-01 NT 10-K NT 10-K 0001193125-26-138017 001-38890 26828692 34 21459
2026-03-30 8-K 8-K 1.02,7.01,9.01 0001193125-26-130489 001-38890 26810104 34 162164 1 1
2026-03-20 8-K 8-K 3.01 0001193125-26-117794 001-38890 26778807 34 144159 1 1
2026-03-05 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000932540-26-000004 005-91007 26727700 34 7395
2026-02-12 8-K 8-K 2.02,8.01 0001193125-26-047544 001-38890 26623208 34 156031 1 1
2026-02-02 8-K 8-K 5.02 0001193125-26-033758 001-38890 26588315 34 135430 1 1
2026-01-29 8-K 8-K 8.01,9.01 0001193125-26-029524 001-38890 26578763 34 169089 1 1
2026-01-23 4 FORM 4 0000912282-26-000121 5618
2026-01-23 4 FORM 4 0000912282-26-000120 5641
2026-01-23 4 FORM 4 0000912282-26-000119 5605
2026-01-21 4 FORM 4 0000912282-26-000089 5496
2026-01-21 4 FORM 4 0000912282-26-000087 5499
2026-01-21 4 FORM 4 0000912282-26-000085 5478
2026-01-21 4 FORM 4 0000912282-26-000083 5472
2025-12-29 144 xsl144X01/primary_doc.xml 0001628280-25-059050 001-38890 251610551 33 4803
2025-12-29 4 FORM 4 0000912282-25-001469 5502
2025-12-29 4 FORM 4 0000912282-25-001468 5465
2025-12-12 4 FORM 4 0000912282-25-001407 6008
2025-12-08 4 FORM 4 0000912282-25-001370 10673
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-112623 005-91007 251487222 34 11469
2025-11-12 10-Q 10-Q 0001193125-25-277529 001-38890 251472622 34 12841947 1 1
2025-11-12 8-K 8-K 2.02,9.01 0001193125-25-277523 001-38890 251472602 34 477084 1 1
2025-10-30 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001140361-25-039832 005-91007 251434295 34 15634
2025-10-17 8-K 8-K 7.01 0001193125-25-242514 001-38890 251400967 34 138806 1 1
2025-10-17 424B5 424B5 0001193125-25-242511 333-283897 251400955 33 71253
2025-09-26 8-K 8-K 1.01,2.03 0001193125-25-220722 001-38890 251351126 34 138825 1 1
2025-08-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-078682 005-91007 251220055 34 11338
2025-08-11 10-Q 10-Q 0000950170-25-106535 001-38890 251202006 34 12653219 1 1
2025-08-11 8-K 8-K 2.02,9.01 0000950170-25-106536 001-38890 251201977 34 456895 1 1
2025-08-05 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002488 333-288971 251187228 33 1863
2025-08-05 424B5 424B5 0001193125-25-173623 333-288971 251186171 33 233350
2025-08-01 CORRESP filename1.htm 0001193125-25-171664 6508
2025-08-01 UPLOAD filename1.pdf 0000000000-25-008116 333-288971 40271
2025-07-25 S-3 S-3 0001193125-25-165524 333-288971 251152333 33 336338
2025-07-16 8-K 8-K 7.01,8.01,9.01 0001193125-25-159886 001-38890 251127761 34 186782 1 1
2025-07-01 D xslFormDX01/primary_doc.xml 06b 0001662774-25-000035 021-550459 251095659 33 15724
2025-06-23 4 xslF345X05/form4.xml 0000912282-25-000697 6354
2025-06-23 4 xslF345X05/form4.xml 0000912282-25-000696 6386
2025-06-23 4 xslF345X05/form4.xml 0000912282-25-000695 6372
2025-06-13 8-K 8-K 1.01,3.02,9.01 0001193125-25-140873 001-38890 251047764 34 827459 1 1
2025-06-06 4 xslF345X05/form4.xml 0000912282-25-000625 5272
2025-06-06 4 xslF345X05/form4.xml 0000912282-25-000623 5793
2025-06-06 4 xslF345X05/form4.xml 0000912282-25-000621 5311
2025-06-06 4 xslF345X05/form4.xml 0000912282-25-000619 5317
2025-06-06 4 xslF345X05/form4.xml 0000912282-25-000617 5338
2025-06-06 4 xslF345X05/form4.xml 0000912282-25-000615 5326
2025-06-06 4 xslF345X05/form4.xml 0000912282-25-000613 5310
2025-06-05 8-K 8-K 5.07 0001662774-25-000034 001-38890 251027236 34 163375 1 1
2025-05-13 10-Q 10-Q 0001662774-25-000032 001-38890 25937387 34 7148031 1 1
2025-05-13 8-K 8-K 2.02,9.01 0001662774-25-000031 001-38890 25937229 34 250280 1 1
2025-04-30 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-042498 005-91007 25894995 34 29991
2025-04-23 ARS ARS 0001662774-25-000027 001-38890 25861478 34 27634813
2025-04-23 DEFA14A DEFA14A 0001662774-25-000026 001-38890 25861360 34 11403209
2025-04-23 DEF 14A DEF 14A 0001662774-25-000025 001-38890 25861329 34 2476696 1 1
2025-04-09 PRE 14A PRE 14A 0001662774-25-000016 001-38890 25825176 34 2500039 1 1
2025-03-24 S-8 S-8 0001193125-25-061463 333-286063 25765130 33 90435
2025-03-24 424B5 424B5 0001193125-25-061458 333-283897 25765090 33 19021
2025-03-24 10-K 10-K 0001662774-25-000012 001-38890 25764226 34 13476720 1 1
2025-03-24 8-K 8-K 2.02,9.01 0001662774-25-000011 001-38890 25764199 34 263486 1 1
2025-02-18 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001140361-25-004984 005-91007 25634158 34 12771
2025-02-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-014182 005-91007 25629562 34 29611
2025-02-11 4 xslF345X05/form4-02112025_100234.xml 0001415889-25-003618 5699
2025-02-11 4 xslF345X05/form4-02112025_100214.xml 0001415889-25-003615 5760
2025-02-11 4 xslF345X05/form4-02112025_100238.xml 0001415889-25-003613 5705
2025-01-08 4 xslF345X05/form4-01092025_120123.xml 0001415889-25-001164 5701
2025-01-08 4 xslF345X05/form4-01092025_120106.xml 0001415889-25-001163 5683
2025-01-08 4 xslF345X05/form4-01092025_120154.xml 0001415889-25-001162 5687
2025-01-08 4 xslF345X05/form4-01092025_120111.xml 0001415889-25-001160 5672
2024-12-27 424B5 424B5 0001628280-24-052494 333-283897 241585703 33 184499
2024-12-26 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-24-003919 333-283897 241582132 33 1870
2024-12-23 CORRESP filename1.htm 0001662774-24-000018 8714
2024-12-23 UPLOAD filename1.pdf 0000000000-24-014218 333-283897 40297
2024-12-18 S-3 S-3 0001628280-24-051856 333-283897 241559157 33 1535464
2024-11-14 SC 13G/A AMENDMENT NO. 2 0001214659-24-019112 005-91007 241461367 34 83953
2024-11-14 8-K 8-K 8.01 0001662774-24-000013 001-38890 241457034 34 151794 1 1
2024-11-13 SC 13D SC 13D 0001193125-24-257646 005-91007 241456564 34 56238
2024-11-13 10-Q 10-Q 0001662774-24-000011 001-38890 241455572 34 11059038 1 1
2024-11-13 8-K 8-K 2.02,9.01 0001662774-24-000010 001-38890 241454412 34 275544 1 1
2024-09-03 4 xslF345X05/form4-09032024_090940.xml 0001415889-24-022702 6945
2024-08-22 4 xslF345X05/form4-08222024_090813.xml 0001415889-24-022054 5245
2024-08-21 4 xslF345X05/form4-08212024_100803.xml 0001415889-24-021869 12053
2024-08-13 10-Q 10-Q 0001662774-24-000005 001-38890 241201562 34 10985070 1 1
2024-08-13 8-K 8-K 2.02,9.01 0001662774-24-000004 001-38890 241201517 34 281548 1 1
2024-08-06 SC 13G/A SC 13G/A 0001104659-24-086395 005-91007 241181035 34 161503
2024-06-21 8-K 8-K 3.01 0001193125-24-165631 001-38890 241060083 34 147655 1 1
2024-06-07 4 xslF345X05/form4-06082024_010656.xml 0001415889-24-016093 5570
2024-06-07 4 xslF345X05/form4-06082024_010616.xml 0001415889-24-016092 5591
2024-06-07 4 xslF345X05/form4-06082024_010657.xml 0001415889-24-016091 5525
2024-06-07 4 xslF345X05/form4-06082024_010651.xml 0001415889-24-016090 5564
2024-06-07 4 xslF345X05/form4-06082024_120627.xml 0001415889-24-016089 5563
2024-06-07 4 xslF345X05/form4-06082024_120618.xml 0001415889-24-016088 6046
2024-06-07 4 xslF345X05/form4-06082024_120623.xml 0001415889-24-016087 5579
2024-06-06 8-K 8-K 5.07 0001193125-24-156202 001-38890 241026432 34 155943 1 1
2024-06-05 4 xslF345X05/form4-06052024_060635.xml 0001415889-24-015533 7137
2024-05-13 10-Q 10-Q 0000950170-24-058201 001-38890 24936880 34 14065531 1 1
2024-04-24 ARS ARS 0001193125-24-110094 001-38890 24870687 34 6831553
2024-04-24 DEFA14A DEFA14A 0001193125-24-110058 001-38890 24870564 34 807370
2024-04-24 DEF 14A DEF 14A 0001193125-24-110034 001-38890 24870488 34 4059455 1 1
2024-04-11 PRE 14A PRE 14A 0001193125-24-093305 001-38890 24838982 34 3964733 1 1
2024-04-01 S-8 S-8 0001193125-24-083605 333-278440 24811038 33 85460
2024-04-01 10-K 10-K 0000950170-24-039440 001-38890 24810353 34 20712373 1 1
2024-02-15 4 xslF345X05/form4-02152024_110201.xml 0001415889-24-003984 5707
2024-02-15 3 xslF345X02/form3-02152024_110211.xml 0001415889-24-003981 11744
2024-02-15 8-K 8-K 5.02 0001193125-24-037521 001-38890 24643681 34 185653 1 1
2024-02-14 SC 13G/A AMENDMENT NO. 1 0001214659-24-002876 005-91007 24637381 34 83345
2024-02-12 SC 13G SC 13G 0001104659-24-013830 005-91007 24617580 34 162787
2024-02-07 SC 13G/A qncx13g020724.htm 0001616824-24-000021 005-91007 24602800 34 82577
2024-02-02 4 xslF345X05/form4-02022024_110255.xml 0001415889-24-002380 5760
2024-02-02 4 xslF345X05/form4-02022024_100258.xml 0001415889-24-002379 5719
2024-02-02 4 xslF345X05/form4-02022024_100215.xml 0001415889-24-002378 5700
2024-01-29 8-K 8-K 5.02 0001193125-24-018071 001-38890 24573525 34 189173 1 1
2024-01-17 4 xslF345X05/form4-01172024_090120.xml 0001415889-24-001313 11073
2024-01-05 8-K/A 8-K/A 9.01 0001193125-24-003344 001-38890 24516165 34 1141301 1 1
2024-01-03 8-K 8-K 8.01 0001193125-24-001482 001-38890 24506199 34 182645 1 1
2023-12-22 8-K 8-K 1.02 0001193125-23-302116 001-38890 231509859 34 204286 1 1
2023-12-15 SC 13G SC 13G 0001140361-23-057682 005-91007 231488214 34 128730
2023-12-14 4 FORM 4 SUBMISSION 0001209191-23-058694 12524
2023-12-08 8-K 8-K 3.01 0001193125-23-291671 001-38890 231475431 34 202952 1 1
2023-12-07 4 FORM 4 SUBMISSION 0001209191-23-057799 10532
2023-12-01 4 FORM 4 SUBMISSION 0001209191-23-057053 11531
2023-11-14 10-Q 10-Q 0000950170-23-063716 001-38890 231406456 34 13174602 1 1
2023-10-26 4 FORM 4 SUBMISSION 0001209191-23-053695 5537
2023-10-26 8-K 8-K 5.02 0001193125-23-264057 001-38890 231350083 34 184692 1 1
2023-10-24 4 FORM 4 SUBMISSION 0001209191-23-053510 6122
2023-10-24 3 FORM 3 SUBMISSION 0001209191-23-053509 8023
2023-10-24 4 FORM 4 SUBMISSION 0001209191-23-053508 5775
2023-10-24 3 FORM 3 SUBMISSION 0001209191-23-053505 7610
2023-10-23 8-K 8-K 1.01,2.01,2.03,5.02,9.01 0001193125-23-260785 001-38890 231340061 34 200524 1 1
2023-09-06 4 FORM 4 SUBMISSION 0001209191-23-048483 5659
2023-09-06 3 FORM 3 SUBMISSION 0001209191-23-048477 7636
2023-09-06 8-K 8-K 1.01,2.03,5.02 0001193125-23-229101 001-38890 231237847 34 194439 1 1
2023-08-31 4 FORM 4 SUBMISSION 0001209191-23-047880 9359
2023-08-17 4 FORM 4 SUBMISSION 0001209191-23-046402 11574
2023-08-11 4 FORM 4 SUBMISSION 0001209191-23-045432 5146
2023-08-10 8-K 8-K 5.02 0001193125-23-209172 001-38890 231160541 34 184740 1 1
2023-08-09 4 FORM 4 SUBMISSION 0001209191-23-045235 5136
2023-08-09 4 FORM 4 SUBMISSION 0001209191-23-045234 5156
2023-08-09 4 FORM 4 SUBMISSION 0001209191-23-045231 5193
2023-08-03 10-Q 10-Q 0000950170-23-038042 001-38890 231140383 34 12920967 1 1
2023-07-24 8-K 8-K 1.01,2.02,2.03,3.02,5.02,7.01,8.01,9.01 0001193125-23-191839 001-38890 231103739 34 10619448 1 1
2023-07-17 SC 13G NONE 0001567619-23-006604 005-91007 231090860 34 82693
2023-05-26 4 FORM 4 SUBMISSION 0001209191-23-032681 9341
2023-05-26 4 FORM 4 SUBMISSION 0001209191-23-032679 9278
2023-05-26 4 FORM 4 SUBMISSION 0001209191-23-032677 9367
2023-05-26 4 FORM 4 SUBMISSION 0001209191-23-032674 9340
2023-05-26 4 FORM 4 SUBMISSION 0001209191-23-032671 9357
2023-05-25 8-K 8-K 5.07 0001193125-23-154245 001-38890 23960968 34 194091 1 1
2023-05-15 10-Q 10-Q 0000950170-23-022241 001-38890 23923017 34 12741561 1 1
2023-04-14 ARS ARS 0001193125-23-102069 001-38890 23821281 34 1827462
2023-04-14 DEFA14A DEFA14A 0001193125-23-102054 001-38890 23821231 34 508844
2023-04-14 DEF 14A DEF 14A 0001193125-23-102037 001-38890 23821168 34 4358050 1 1
2023-04-05 8-A12B 8-A12B 0001193125-23-092432 001-38890 23803485 34 16896
2023-04-05 8-K 8-K 1.01,3.03,5.03,8.01,9.01 0001193125-23-092414 001-38890 23803395 34 556878 1 1
2023-04-04 PRE 14A PRE 14A 0001193125-23-090937 001-38890 23798332 34 4358856 1 1
2023-03-31 SC 13G r322230sc13g.htm 0001214659-23-004596 005-91007 23787326 34 91117
2023-03-28 8-K 8-K 5.02 0001193125-23-082305 001-38890 23770444 34 142742 1 1
2023-03-15 S-8 S-8 0001193125-23-071454 333-270577 23736061 33 78753
2023-03-15 10-K 10-K 0000950170-23-008148 001-38890 23735425 34 15708203 1 1
2023-03-06 4 FORM 4 SUBMISSION 0001209191-23-016507 5038
2023-03-03 8-K 8-K 5.02 0001193125-23-060044 001-38890 23704114 34 145866 1 1
2023-02-13 SC 13G/A QNCX_13G_A4 0001779453-23-000006 005-91007 23620190 34 77248
2023-02-02 4 FORM 4 SUBMISSION 0001209191-23-006402 5657
2023-02-02 4 FORM 4 SUBMISSION 0001209191-23-006401 5726
2023-02-02 4 FORM 4 SUBMISSION 0001209191-23-006398 5694
2023-02-02 4 FORM 4 SUBMISSION 0001209191-23-006394 5677
2023-01-30 8-K 8-K 2.02,2.05,8.01 0001193125-23-019103 001-38890 23568015 34 160726 1 1
2023-01-27 8-K 8-K 1.01,5.02 0001193125-23-017549 001-38890 23562990 34 158595 1 1
2022-12-16 8-K 8-K 3.01 0001193125-22-307303 001-38890 221467937 34 145258 1 1
2022-12-07 4 FORM 4 SUBMISSION 0001209191-22-060218 5039
2022-11-09 10-Q 10-Q 0000950170-22-023877 001-38890 221372857 34 13098908 1 1
2022-09-30 8-K 8-K 5.02 0001193125-22-255696 001-38890 221284852 34 143858 1 1
2022-09-08 4 FORM 4 SUBMISSION 0001209191-22-049221 5039
2022-08-09 10-Q 10-Q 0000950170-22-016102 001-38890 221148724 34 16300383 1 1
2022-08-01 8-K 8-K 2.02,5.03,8.01,9.01 0001193125-22-207867 001-38890 221123037 34 393845 1 1
2022-07-22 8-K 8-K 5.02 0001193125-22-200068 001-38890 221100189 34 178351 1 1
2022-07-08 SC 13G/A SEC SCHEDULE 13G 0001422849-22-000154 005-91007 221073668 34 18154
2022-07-01 4 FORM 4 SUBMISSION 0001209191-22-040306 9164
2022-06-10 8-K 8-K 1.01,2.03,5.02,5.07 0001193125-22-172060 001-38890 221009718 34 166406 1 1
2022-06-10 4 FORM 4 SUBMISSION 0001209191-22-035877 5295
2022-06-10 3 FORM 3 SUBMISSION 0001209191-22-035870 6748
2022-06-09 4 FORM 4 SUBMISSION 0001209191-22-035678 5288
2022-06-09 4 FORM 4 SUBMISSION 0001209191-22-035674 5249
2022-06-09 4 FORM 4 SUBMISSION 0001209191-22-035672 5297
2022-06-09 4 FORM 4 SUBMISSION 0001209191-22-035671 5315
2022-06-08 4 FORM 4 SUBMISSION 0001209191-22-035020 4914
2022-06-08 4 FORM 4 SUBMISSION 0001209191-22-035017 5433
2022-06-08 4 FORM 4 SUBMISSION 0001209191-22-035014 6942
2022-05-27 4/A FORM 4/A SUBMISSION 0001209191-22-032677 5791
2022-05-27 4/A FORM 4/A SUBMISSION 0001209191-22-032675 5722
2022-05-27 4/A FORM 4/A SUBMISSION 0001209191-22-032672 5742
2022-05-25 DEFA14A DEFA14A 0001193125-22-159688 001-38890 22962944 34 26342
2022-05-23 4 FORM 4 SUBMISSION 0001209191-22-031515 10179
2022-05-23 3 FORM 3 SUBMISSION 0001209191-22-031511 6758
2022-05-23 4 FORM 4 SUBMISSION 0001209191-22-031508 10248
2022-05-23 3 FORM 3 SUBMISSION 0001209191-22-031506 6844
2022-05-23 4 FORM 4 SUBMISSION 0001209191-22-031503 9295
2022-05-23 3 FORM 3 SUBMISSION 0001209191-22-031502 6725
2022-05-23 4 FORM 4 SUBMISSION 0001209191-22-031500 7236
2022-05-23 4 FORM 4 SUBMISSION 0001209191-22-031498 10196
2022-05-23 3 FORM 3 SUBMISSION 0001209191-22-031493 6798
2022-05-20 S-8 S-8 0001193125-22-156129 333-265109 22947613 33 387170
2022-05-20 8-K 8-K 2.01,5.02 0001193125-22-155640 001-38890 22945328 34 145493 1 1
2022-05-19 424B5 424B5 0001193125-22-155097 333-238851 22943736 33 133453
2022-05-17 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001193125-22-066056,2022-05-17 9999999995-22-001501 333-238851 22936934 33 1701
2022-05-17 POS EX POS EX 0001193125-22-152218 333-238851 22931941 33 77790
2022-05-12 8-K 8-K 1.01,2.02,3.02,5.02,9.01 0001193125-22-148822 001-38890 22918942 34 936041 1 1
2022-05-10 10-Q 10-Q 0000950170-22-009040 001-38890 22910637 34 9507248 1 1
2022-05-10 8-K 8-K 8.01,9.01 0001193125-22-145747 001-38890 22907467 34 170793 1 1
2022-05-02 8-K 8-K 2.05,5.02 0001193125-22-137040 001-38890 22883366 34 144716 1 1
2022-04-27 DEFA14A DEFA14A 0001193125-22-123573 001-38890 22859458 34 620145
2022-04-27 DEF 14A DEF 14A 0001193125-22-123565 001-38890 22859438 34 1518126
2022-03-16 4 FORM 4 SUBMISSION 0001209191-22-019311 5307
2022-03-16 3 FORM 3 SUBMISSION 0001209191-22-019305 6735
2022-03-15 8-K 8-K 5.02 0001193125-22-076267 001-38890 22742128 34 143688 1 1
2022-03-04 4 FORM 4 SUBMISSION 0001209191-22-016443 4967
2022-03-04 4 FORM 4 SUBMISSION 0001209191-22-016441 4929
2022-03-04 4 FORM 4 SUBMISSION 0001209191-22-016440 4964
2022-03-04 4 FORM 4 SUBMISSION 0001209191-22-016429 4990
2022-03-04 4 FORM 4 SUBMISSION 0001209191-22-016428 4986
2022-03-04 POS AM POS AM 0001193125-22-066056 333-238851 22714017 33 401263
2022-03-01 S-8 S-8 0001193125-22-061705 333-263186 22699938 33 80331
2022-03-01 10-K 10-K 0000950170-22-002571 001-38890 22699367 34 13358389 1 1
2022-02-14 SC 13G/A SC 13G/A 3 CORTEXYME 0000078003-22-000018 005-91007 22623350 34 76994
2022-02-11 SC 13G/A SEC SCHEDULE 13G 0001422849-22-000060 005-91007 22619662 34 18133
2022-02-11 SC 13G/A SEC SCHEDULE 13G 0001422848-22-000169 005-91007 22618501 34 18129
2022-02-07 POSASR POSASR 0001193125-22-029752 333-238851 22598351 33 786510
2022-02-02 8-K 8-K 2.02,2.05,5.02,8.01 0001193125-22-025869 001-38890 22584549 34 168948 1 1
2022-01-26 8-K 8-K 8.01 0001193125-22-017740 001-38890 22555739 34 145211 1 1
2022-01-05 4 FORM 4 SUBMISSION 0001209191-22-001824 5522
2022-01-05 4 FORM 4 SUBMISSION 0001209191-22-001792 5478
2022-01-05 4 FORM 4 SUBMISSION 0001209191-22-001788 5520
2022-01-05 4 FORM 4 SUBMISSION 0001209191-22-001759 5523
2022-01-05 4 FORM 4 SUBMISSION 0001209191-22-001754 5538
2022-01-05 4 FORM 4 SUBMISSION 0001209191-22-001752 5535
2022-01-05 4 FORM 4 SUBMISSION 0001209191-22-001731 5327
2021-12-23 8-K 8-K 1.01,9.01 0001193125-21-366374 001-38890 211518189 34 400729 1 1
2021-12-23 424B5 424B5 0001193125-21-366368 333-238851 211518169 33 279145
2021-12-10 SC 13G/A SEC SCHEDULE 13G 0001562230-21-000135 005-91007 211485371 34 18243
2021-12-10 SC 13G/A SEC SCHEDULE 13G 0001562230-21-000137 005-91007 211484874 34 18243
2021-11-19 4 FORM 4 SUBMISSION 0001209191-21-065993 9261
2021-11-16 4 FORM 4 SUBMISSION 0001209191-21-064924 7010
2021-11-12 4 FORM 4 SUBMISSION 0001209191-21-064346 5990
2021-10-29 10-Q 10-Q 0000950170-21-002495 001-38890 211360940 34 8898065 1 1
2021-10-26 8-K 8-K 8.01 0001193125-21-307962 001-38890 211348527 34 151014 1 1
2021-10-12 4 FORM 4 SUBMISSION 0001209191-21-060264 8682
2021-10-08 SC 13G/A SEC SCHEDULE 13G 0001562230-21-000134 005-91007 211314524 34 18245
2021-10-08 SC 13G/A SEC SCHEDULE 13G 0001562230-21-000132 005-91007 211314503 34 18245
2021-10-07 4 FORM 4 SUBMISSION 0001209191-21-059984 8627
2021-08-18 4 FORM 4 SUBMISSION 0001209191-21-052285 16913
2021-08-18 4 FORM 4 SUBMISSION 0001209191-21-052277 20655
2021-08-12 4 FORM 4 SUBMISSION 0001209191-21-051214 8757
2021-08-06 10-Q 10-Q 0000950170-21-001015 001-38890 211153231 34 9215286 1 1
2021-07-07 4 FORM 4 SUBMISSION 0001209191-21-045948 26853
2021-06-30 4 FORM 4 SUBMISSION 0001209191-21-044027 19098
2021-06-29 4 FORM 4 SUBMISSION 0001209191-21-043707 7837
2021-06-21 8-K 8-K 5.07 0001193125-21-193522 001-38890 211026847 34 154765 1 1
2021-06-17 4 FORM 4 SUBMISSION 0001209191-21-041719 5290
2021-06-17 4 FORM 4 SUBMISSION 0001209191-21-041716 5251
2021-06-17 4 FORM 4 SUBMISSION 0001209191-21-041714 5317
2021-06-17 4 FORM 4 SUBMISSION 0001209191-21-041711 5299
2021-05-18 8-K 8-K 1.01,2.03 0001193125-21-165311 001-38890 21935982 34 141649 1 1
2021-05-12 4 FORM 4 SUBMISSION 0001209191-21-032078 13725
2021-05-06 10-Q 10-Q 0001564590-21-025001 001-38890 21898075 34 8147987 1 1
2021-04-30 DEFA14A DEFA14A 0001193125-21-144941 001-38890 21877679 34 294815
2021-04-30 DEF 14A DEF 14A 0001193125-21-141486 001-38890 21873099 34 1979831
2021-04-27 SC 13G/A SC 13G/A 0001193125-21-133435 005-91007 21856845 34 35955
2021-03-25 SC 13G/A CORTEXYME SC 13G/A 2 0000078003-21-000051 005-91007 21772590 34 68030
2021-03-24 4 FORM 4 SUBMISSION 0001209191-21-022947 6966
2021-03-23 4 FORM 4 SUBMISSION 0001209191-21-022688 6778
2021-03-23 4 FORM 4 SUBMISSION 0001209191-21-022682 13200
2021-03-10 SC 13G/A SEC SCHEDULE 13G 0001422849-21-000132 005-91007 21729191 34 18102
2021-03-05 4 FORM 4 SUBMISSION 0001209191-21-018328 12644
2021-03-01 S-8 S-8 0001193125-21-063853 333-253743 21699493 33 68145
2021-03-01 10-K 10-K 0001564590-21-009867 001-38890 21697960 34 11640739 1
2021-02-16 SC 13G SEC SCHEDULE 13G 0001562230-21-000041 005-91007 21636273 34 18184
2021-02-16 SC 13G SEC SCHEDULE 13G 0001562230-21-000024 005-91007 21635929 34 18184
2021-02-16 SC 13G/A SEC SCHEDULE 13G 0001422848-21-000043 005-91007 21635436 34 18146
2021-02-16 SC 13G SEC SCHEDULE 13G 0001422849-21-000043 005-91007 21635014 34 18069
2021-02-16 8-K 8-K 8.01,9.01 0001193125-21-043200 001-38890 21632054 34 162388 1 1
2021-02-16 SC 13G/A CORTEXYME SC 13G/A 0000078003-21-000028 005-91007 21630117 34 66295
2021-02-11 4 FORM 4 SUBMISSION 0001209191-21-009949 5443
2021-02-11 3 FORM 3 SUBMISSION 0001209191-21-009947 10308
2021-02-11 4 FORM 4 SUBMISSION 0001209191-21-009920 5454
2021-02-10 8-K 8-K 5.02 0001193125-21-036344 001-38890 21614353 34 145324 1 1
2021-02-03 4 FORM 4 SUBMISSION 0001209191-21-007540 42842
2021-02-01 5 PRIMARY DOCUMENT 0001779453-21-000001 4883
2021-02-01 SC 13G/A CRTX13GA3 0001771620-21-000001 005-91007 21576993 34 77117
2021-01-29 SC 13G/A SC 13G/A 0001395064-21-000016 005-91007 21566999 34 128083
2021-01-26 8-K 8-K 2.02,8.01,9.01 0001193125-21-017064 001-38890 21551765 34 172770 1 1
2021-01-25 8-K 8-K 5.02 0001193125-21-016445 001-38890 21550729 34 22155
2020-12-15 4 FORM 4 SUBMISSION 0001209191-20-063615 22106
2020-12-15 4 FORM 4 SUBMISSION 0001209191-20-063609 12387
2020-12-15 4 FORM 4 SUBMISSION 0001209191-20-063604 12420
2020-12-15 4 FORM 4 SUBMISSION 0001209191-20-063602 12427
2020-12-15 4 FORM 4 SUBMISSION 0001209191-20-063601 12392
2020-12-15 4 FORM 4 SUBMISSION 0001209191-20-063600 8485
2020-12-14 4 FORM 4 SUBMISSION 0001209191-20-063277 10908
2020-12-04 8-K 8-K 8.01 0001193125-20-310020 001-38890 201368721 34 21825
2020-11-12 10-Q 10-Q 0001564590-20-053571 001-38890 201306886 34 7524056 1
2020-08-14 10-Q 10-Q 0001564590-20-040300 001-38890 201105529 34 7769383 1
2020-06-15 4 PRIMARY DOCUMENT 0001779453-20-000005 8637
2020-06-10 8-K 8-K 5.07 0001193125-20-165699 001-38890 20954859 34 23971
2020-06-09 4 FORM 4 SUBMISSION 0001209191-20-035425 9272
2020-06-09 4 FORM 4 SUBMISSION 0001209191-20-035424 9296
2020-06-09 4 FORM 4 SUBMISSION 0001209191-20-035423 9237
2020-06-09 4 FORM 4 SUBMISSION 0001209191-20-035421 9319
2020-06-09 4 FORM 4 SUBMISSION 0001209191-20-035419 5378
2020-06-08 4 FORM 4 SUBMISSION 0001209191-20-035104 13923
2020-06-04 4 PRIMARY DOCUMENT 0000078003-20-000038 8553
2020-06-01 S-3ASR S-3ASR 0001193125-20-157335 333-238851 20933947 33 671201
2020-05-29 4 FORM 4 SUBMISSION 0001209191-20-032970 10913
2020-05-22 4 PRIMARY DOCUMENT 0001779453-20-000002 11716
2020-05-21 8-K 8-K 5.02,9.01 0001193125-20-148723 001-38890 20902275 34 73108
2020-05-19 4 FORM 4 SUBMISSION 0001209191-20-030688 22143
2020-05-18 4 FORM 4 SUBMISSION 0001209191-20-030022 5418
2020-05-18 4 FORM 4 SUBMISSION 0001209191-20-030020 5361
2020-05-15 4 FORM 4 SUBMISSION 0001209191-20-029819 5346
2020-05-15 3 FORM 3 SUBMISSION 0001209191-20-029809 6834
2020-05-12 8-K 8-K 2.02,9.01 0001193125-20-140538 001-38890 20869712 34 77844
2020-05-12 10-Q 10-Q 0001564590-20-024670 001-38890 20869323 34 6784733 1
2020-04-30 8-K 8-K 5.02 0001193125-20-128936 001-38890 20836540 34 18900
2020-04-22 DEFA14A DEFA14A 0001564590-20-017901 001-38890 20807891 34 147575
2020-04-22 DEF 14A DEF 14A 0001564590-20-017899 001-38890 20807877 34 908115
2020-04-13 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2020-04-13 16:00:00 9999999995-20-000739 333-237594 20789980 33 1688
2020-04-13 424B3 424B3 0001193125-20-105265 333-237594 20788981 33 209124
2020-04-09 CORRESP filename1.htm 0001193125-20-102554 14801
2020-04-08 UPLOAD filename1.pdf 0000000000-20-003043 39817
2020-04-07 S-1 S-1 0001193125-20-100556 333-237594 20780405 33 308173
2020-04-06 4 FORM 4 SUBMISSION 0001209191-20-023626 7016

Latest XBRL company facts

One latest value per concept from companyfacts (354 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 10.84M 2026-11-05 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
dei EntityPublicFloat Entity Public Float USD 64.00M 2025-06-30 2025 FY 10-K 2026-04-10 0001193125-26-151364
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 1.73M 2025-01-01 2025-12-31 DEF 14A 2026-08-25 0001193125-26-364220
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 1.17M 2025-01-01 2025-12-31 DEF 14A 2026-08-25 0001193125-26-364220
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 3.94M 2025-01-01 2025-12-31 DEF 14A 2026-08-25 0001193125-26-364220
ecd PeoTotalCompAmt PeoTotalCompAmt USD 2.41M 2025-01-01 2025-12-31 DEF 14A 2026-08-25 0001193125-26-364220
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 525.57 2025-01-01 2025-12-31 DEF 14A 2026-08-25 0001193125-26-364220
ffd NetFeeAmt NetFeeAmt USD 3,322.53 2026-11-18 S-8 2026-11-19 0001193125-26-468531
ffd TtlFeeAmt TtlFeeAmt USD 3,322.53 2026-11-18 S-8 2026-11-19 0001193125-26-468531
ffd TtlOfferingAmt TtlOfferingAmt USD 38.19M 2026-11-18 S-8 2026-11-19 0001193125-26-468531
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-11-18 S-8 2026-11-19 0001193125-26-468531
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-07-28 S-3 2026-07-31 0001193125-26-328769
us-gaap AccountsAndOtherReceivablesNetCurrent Accounts and Other Receivables, Net, Current USD 500,000 2023-09-30 2023 Q3 10-Q 2023-11-14 0000950170-23-063716
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 1.45M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap AccretionExpense Accretion Expense USD 694,000 2018-01-01 2018-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009867
us-gaap AccruedIncomeTaxesNoncurrent Accrued Income Taxes, Noncurrent USD 553,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 5.77M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 896,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 19,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -17,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 462.08M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 406.61M 2024-12-31 2024 FY 10-K 2025-03-24 0001662774-25-000012
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 15.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 15.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 5.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap Assets Assets USD 106.47M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap AssetsCurrent Assets, Current USD 106.30M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 104.53M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 37,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 104.57M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 USD 0 2023-12-31 2023 FY 10-K 2024-04-01 0000950170-24-039440
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 0 2023-12-31 2023 FY 10-K 2024-04-01 0000950170-24-039440
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10 USD 0 2023-12-31 2023 FY 10-K 2024-04-01 0000950170-24-039440
us-gaap AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value USD 54.31M 2023-12-31 2023 FY 10-K 2024-04-01 0000950170-24-039440
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One USD 54.31M 2023-12-31 2023 FY 10-K 2024-04-01 0000950170-24-039440
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 104.53M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 65.42M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap AvailableForSaleSecuritiesDebtSecuritiesNoncurrent Debt Securities, Available-for-sale, Noncurrent USD 0 2023-12-31 2023 FY 10-K 2024-04-01 0000950170-24-039440
us-gaap BusinessAcquisitionsProFormaNetIncomeLoss Business Acquisition, Pro Forma Net Income (Loss) USD -52.59M 2022-01-01 2022-12-31 2023 FY 10-K 2024-04-01 0000950170-24-039440
us-gaap BusinessAcquisitionsProFormaRevenue Business Acquisition, Pro Forma Revenue USD 262,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-04-01 0000950170-24-039440
us-gaap BusinessCombinationAcquisitionRelatedCosts Business Combination, Acquisition Related Costs USD 2.50M 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0000950170-24-039440
us-gaap BusinessCombinationBargainPurchaseGainRecognizedAmount Business Combination, Bargain Purchase, Gain Recognized, Amount USD 1.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability USD -64.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap BusinessCombinationContingentConsiderationLiability Business Combination, Contingent Consideration, Liability USD 56.69M 2024-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap BusinessCombinationContingentConsiderationLiabilityCurrent Business Combination, Contingent Consideration, Liability, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap BusinessCombinationContingentConsiderationLiabilityNoncurrent Business Combination, Contingent Consideration, Liability, Noncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents USD 10.59M 2022-05-19 2023 FY 10-K 2024-04-01 0000950170-24-039440
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets USD 1.04M 2022-05-19 2023 FY 10-K 2024-04-01 0000950170-24-039440
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable USD 1.73M 2022-05-19 2023 FY 10-K 2024-04-01 0000950170-24-039440
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities USD 532,000 2022-05-19 2023 FY 10-K 2024-04-01 0000950170-24-039440
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill USD 5.90M 2022-05-19 2023 FY 10-K 2024-04-01 0000950170-24-039440
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment USD 279,000 2022-05-19 2023 FY 10-K 2024-04-01 0000950170-24-039440
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net USD 15.68M 2022-05-19 2023 FY 10-K 2024-04-01 0000950170-24-039440
us-gaap Cash Cash USD 709,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap CashAcquiredFromAcquisition Cash Acquired from Acquisition USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0000950170-24-039440
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 39.82M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 21.81M 2024-03-31 2024 Q1 10-Q 2024-05-13 0000950170-24-058201
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 105.20M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 39.82M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 7.21M 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-06 0000950170-21-001015
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 34.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 11.12M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 400,000 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 0.03 2014-06-30 2021 FY 10-K 2022-03-01 0000950170-22-002571
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 27,941 2014-06-30 2021 FY 10-K 2022-03-01 0000950170-22-002571
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 0 2019-12-31 2019 FY 10-K 2020-03-16 0001564590-20-011165
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 18.14M 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 250.00M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 1.02M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 1.02M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap CommonStockValue Common Stock, Value, Issued USD 1,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -73.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap ConvertibleNotesPayable Convertible Notes Payable USD 8.00M 2019-01-31 2020 FY 10-K 2021-03-01 0001564590-21-009867
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 241,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 8.57M 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 8.80M 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD -9,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 11.76M 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap DebtInstrumentFairValue Debt Instrument, Fair Value Disclosure USD 18.03M 2025-12-31 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue USD 0 2026-06-30 2026 Q2 10-Q 2026-08-14 0001193125-26-352201
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer USD 3.70M 2023-12-31 2023 FY 10-K 2024-04-01 0000950170-24-039440
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss USD 23,000 2023-12-31 2023 FY 10-K 2024-04-01 0000950170-24-039440
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months USD 3.97M 2023-12-31 2023 FY 10-K 2024-04-01 0000950170-24-039440
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss USD 0 2023-12-31 2023 FY 10-K 2024-04-01 0000950170-24-039440
us-gaap DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent USD 11.94M 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap DebtSecuritiesAvailableForSaleRealizedGainLoss Debt Securities, Available-for-sale, Realized Gain (Loss) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPosition Debt Securities, Available-for-sale, Unrealized Loss Position USD 7.67M 2023-12-31 2023 FY 10-K 2024-04-01 0000950170-24-039440
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss USD 23,000 2023-12-31 2023 FY 10-K 2024-04-01 0000950170-24-039440
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions Security 0 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap DeferredCompensationLiabilityCurrent Deferred Compensation Liability, Current USD 3.00M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap DeferredFinanceCostsCurrentNet Debt Issuance Costs, Current, Net USD 1.13M 2019-03-31 2019 Q1 10-Q 2019-06-12 0001564590-19-022340
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD -5.59M 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD -5.59M 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 109,000 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap DeferredIncomeTaxLiabilitiesNet Deferred Income Tax Liabilities, Net USD 0 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 85.18M 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 13.25M 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 247,000 2022-12-31 2022 FY 10-K 2023-03-15 0000950170-23-008148
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 109,000 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 59.69M 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 8.01M 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsForeign Deferred Tax Assets, Tax Credit Carryforwards, Foreign USD 229,000 2026-06-30 2026 Q2 10-Q 2026-08-14 0001193125-26-352201
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 2.90M 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other USD 604,000 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 85.07M 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 0 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 0 2023-12-31 2023 FY 10-K 2024-04-01 0000950170-24-039440
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 45,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 100 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0000950170-24-039440
us-gaap DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent pure 1 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap Depreciation Depreciation USD 100,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 92,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -10.79 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.72 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-10 0000950170-22-009040
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -10.79 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure -0.04 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure 0.005 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0.04 2024-01-01 2024-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap EffectiveIncomeTaxRateReconciliationGiltiAmount EffectiveIncomeTaxRateReconciliationGiltiAmount USD 6.54M 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap EffectiveIncomeTaxRateReconciliationGiltiPercent EffectiveIncomeTaxRateReconciliationGiltiPercent pure -0.081 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Percent pure 0.083 2024-01-01 2024-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.008 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure -0.003 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0001662774-25-000012
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure -0.221 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure -0.004 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD -211,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 0 2024-09-30 2024 Q3 10-Q 2024-11-13 0001662774-24-000011
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 54.00M 2020-09-30 2020 Q3 10-Q 2020-11-12 0001564590-20-053571
us-gaap EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense Share-based Payment Arrangement, Expense, Tax Benefit USD 0 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-13 0000950170-24-058201
us-gaap EquityMethodInvestments Equity Method Investments USD 78,000 2026-06-30 2026 Q2 10-Q 2026-08-14 0001193125-26-352201
us-gaap EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount USD 0 2023-09-30 2023 Q3 10-Q 2023-11-14 0000950170-23-063716
us-gaap EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount USD 0 2023-09-30 2023 Q3 10-Q 2023-11-14 0000950170-23-063716
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD -21.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap FairValueAssetsLevel1ToLevel2TransfersAmount Fair Value, Assets, Level 1 to Level 2 Transfers, Amount USD 0 2022-03-31 2022 Q1 10-Q 2022-05-10 0000950170-22-009040
us-gaap FairValueAssetsLevel2ToLevel1TransfersAmount Fair Value, Assets, Level 2 to Level 1 Transfers, Amount USD 0 2022-03-31 2022 Q1 10-Q 2022-05-10 0000950170-22-009040
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0000950170-24-039440
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements USD 5.00M 2024-07-01 2024-09-30 2024 Q3 10-Q 2024-11-13 0001662774-24-000011
us-gaap FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Earnings USD -206,000 2018-01-01 2018-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009867
us-gaap FairValueOfAssetsAcquired Fair Value of Assets Acquired USD 4.16M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap FairValueOptionChangesInFairValueGainLoss1 Fair Value, Option, Changes in Fair Value, Gain (Loss) USD 21.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 70,000 2023-02-28 2023 FY 10-K 2024-04-01 0000950170-24-039440
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 19,000 2022-09-30 2022 Q3 10-Q 2022-11-09 0000950170-22-023877
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0001662774-25-000012
us-gaap FinanceLeaseRightOfUseAsset Finance Lease, Right-of-Use Asset, after Accumulated Amortization USD 0 2023-12-31 2023 FY 10-K 2024-04-01 0000950170-24-039440
us-gaap FinanceLeaseRightOfUseAssetAmortization Finance Lease, Right-of-Use Asset, Amortization USD 6,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0000950170-24-039440
us-gaap FinanceLeaseWeightedAverageDiscountRatePercent Finance Lease, Weighted Average Discount Rate, Percent pure 0 2023-12-31 2023 FY 10-K 2024-04-01 0000950170-24-039440
us-gaap FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss Finite Lived Intangible Assets, Foreign Currency Translation Gain (Loss) USD 36,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD 477,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap ForeignIncomeTaxExpenseBenefitContinuingOperations Foreign Income Tax Expense (Benefit), Continuing Operations USD 68,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD 1.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap GainLossOnSaleOfBusiness Gain (Loss) on Disposition of Business USD 1.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap GainLossOnSaleOfInvestments Gain (Loss) on Sale of Investments USD 0 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-13 0001662774-24-000011
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -9,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 29.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap Goodwill Goodwill USD 0 2024-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap GoodwillAcquiredDuringPeriod Goodwill, Acquired During Period USD 16.93M 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0000950170-24-039440
us-gaap GoodwillAndIntangibleAssetImpairment Goodwill and Intangible Asset Impairment USD 825,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-15 0000950170-23-008148
us-gaap GoodwillForeignCurrencyTranslationGainLoss Goodwill, Foreign Currency Translation Gain (Loss) USD -495,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap ImpairmentOfIntangibleAssetsExcludingGoodwill Impairment of Intangible Assets (Excluding Goodwill) USD 67.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap ImpairmentOfIntangibleAssetsFinitelived Impairment of Intangible Assets, Finite-lived USD 447,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) USD 67.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -56.47M 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -80.77M 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD -24.30M 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap IncomeLossIncludingPortionAttributableToNoncontrollingInterest Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax USD -72.89M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap IncomeTaxExaminationPenaltiesAndInterestAccrued Income Tax Examination, Penalties and Interest Accrued USD 200,000 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD -5.57M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD -403,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -16.96M 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 194,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 681,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap IncomeTaxReconciliationOtherReconcilingItems Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount USD 67,000 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-13 0001662774-24-000005
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 1,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 17.85M 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap IncomeTaxReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Amount USD 311,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 3.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD -12.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap IncreaseDecreaseInDeferredIncomeTaxes Increase (Decrease) in Deferred Income Taxes USD 4.96M 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap IncreaseDecreaseInOtherCurrentAssets Increase (Decrease) in Other Current Assets USD -1.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD -165,000 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-10 0000950170-22-009040
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD -766,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -3.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap IndefiniteLivedIntangibleAssetsExcludingGoodwill Indefinite-lived Intangible Assets (Excluding Goodwill) USD 0 2023-09-30 2023 Q3 10-Q 2023-11-14 0000950170-23-063716
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap InterestExpense Interest Expense USD 957,000 2018-01-01 2018-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009867
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 29,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap InvestmentIncomeAmortizationOfDiscount Investment Income, Amortization of Discount USD 812,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-16 0001564590-20-011165
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 1.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap InvestmentIncomeNet Investment Income, Net USD 2.19M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-16 0001564590-20-011165
us-gaap InvestmentIncomeNetAmortizationOfDiscountAndPremium Investment Income, Net, Amortization of Discount and Premium USD 604,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 387,000 2018-01-01 2018-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009867
us-gaap LeaseCost Lease, Cost USD 368,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0000950170-24-039440
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 48,000 2023-12-31 2023 FY 10-K 2024-04-01 0000950170-24-039440
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 139,000 2026-03-31 2026 Q1 10-Q 2026-05-11 0001193125-26-217098
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 69,000 2023-12-31 2023 FY 10-K 2024-04-01 0000950170-24-039440
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 101,000 2025-09-30 2025 Q3 10-Q 2025-11-12 0001193125-25-277529
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 128,000 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 125,000 2026-03-31 2026 Q1 10-Q 2026-05-11 0001193125-26-217098
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 108,000 2026-03-31 2026 Q1 10-Q 2026-05-11 0001193125-26-217098
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 65,000 2026-03-31 2026 Q1 10-Q 2026-05-11 0001193125-26-217098
us-gaap Liabilities Liabilities USD 28.37M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 106.47M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap LiabilitiesAssumed1 Liabilities Assumed USD 9.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap LiabilitiesCurrent Liabilities, Current USD 7.22M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap LiabilitiesFairValueDisclosure Financial and Nonfinancial Liabilities, Fair Value Disclosure USD 20.59M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap LiabilityForUncertainTaxPositionsCurrent Liability for Uncertainty in Income Taxes, Current USD 0 2022-12-31 2022 FY 10-K 2023-03-15 0000950170-23-008148
us-gaap LongTermDebt Long-term Debt USD 0 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 11.76M 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 11.05M 2023-12-31 2023 FY 10-K 2024-04-01 0000950170-24-039440
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 10.41M 2024-12-31 2024 FY 10-K 2025-03-24 0001662774-25-000012
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear Long-Term Debt, Maturity, Remainder of Fiscal Year USD 0 2025-09-30 2025 Q3 10-Q 2025-11-12 0001193125-25-277529
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 118.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -47.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -36.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -67.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -67.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -67.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1 Noncash or Part Noncash Acquisition, Net Nonmonetary Assets Acquired (Liabilities Assumed) USD 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0000950170-23-063716
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap OperatingExpenses Operating Expenses USD 107.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -107.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap OperatingLeaseCost Operating Lease, Cost USD 266,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0000950170-24-039440
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 100,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap OperatingLeaseImpairmentLoss Operating Lease, Impairment Loss USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0001662774-25-000012
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 445,000 2025-12-31 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap OperatingLeasePayments Operating Lease, Payments USD 1.30M 2021-07-01 2021-07-31 2022 FY 10-K 2023-03-15 0000950170-23-008148
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.091 2025-12-31 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 28.00M 2019-03-31 2019 Q1 10-Q 2019-06-12 0001564590-19-022340
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 53,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap OtherAccruedLiabilitiesNoncurrent Other Accrued Liabilities, Noncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap OtherAssets Other Assets USD 78,000 2026-06-30 2026 Q2 10-Q 2026-08-14 0001193125-26-352201
us-gaap OtherAssetsCurrent Other Assets, Current USD 65,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 106,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent USD -396,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment, after Tax USD -42,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD -3.16M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0001662774-25-000012
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax USD 5.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD -655,000 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-09 0000950170-22-023877
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 556,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 255,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap OtherRestructuringCosts Other Restructuring Costs USD 100,000 2023-01-31 2023-04-30 2024 FY 10-K 2025-03-24 0001662774-25-000012
us-gaap OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale USD 0 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-09 0000950170-22-023877
us-gaap PaidInKindInterest Paid-in-Kind Interest USD 263,000 2018-01-01 2018-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009867
us-gaap PaymentForContingentConsiderationLiabilityFinancingActivities Payment for Contingent Consideration Liability, Financing Activities USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap PaymentsForRepurchaseOfInitialPublicOffering Payments for Repurchase of Initial Public Offering USD 34,000 2018-01-01 2018-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009867
us-gaap PaymentsForRepurchaseOfWarrants Payments for Repurchase of Warrants USD 66,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 12,000 2018-01-01 2018-03-31 2019 Q1 10-Q 2019-06-12 0001564590-19-022340
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 64.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD -8.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 85.72M 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-13 0001662774-24-000005
us-gaap PaymentsToAcquireNotesReceivable Payments to Acquire Notes Receivable USD 0 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-13 0001662774-24-000011
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 71,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 1.06M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 538,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap PrepaidInsurance Prepaid Insurance USD 80,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap PriorPeriodReclassificationAdjustment Prior Period Reclassification Adjustment USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0000950170-24-039440
us-gaap ProceedsFromDivestitureOfBusinesses Proceeds from Divestiture of Businesses USD 450,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap ProceedsFromDivestitureOfBusinessesNetOfCashDivested Proceeds from Divestiture of Businesses, Net of Cash Divested USD 450,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0000950170-22-002571
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0000950170-24-039440
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 75.69M 2018-01-01 2018-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009867
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-15 0000950170-23-008148
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 250,000 2018-01-01 2018-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009867
us-gaap ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities Proceeds from Sale and Maturity of Debt Securities, Available-for-sale USD 12.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap ProceedsFromSaleMaturityAndCollectionsOfInvestments Proceeds from Sale, Maturity and Collection of Investments USD 89.73M 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-13 0001662774-24-000005
us-gaap ProceedsFromSaleOfProductiveAssets Proceeds from Sale of Productive Assets USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0001662774-25-000012
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0000950170-22-002571
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -56.83M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0001662774-25-000012
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 424,000 2019-09-30 2019 Q3 10-Q 2019-11-12 0001564590-19-042988
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 69,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap ReceivablesNetCurrent Receivables, Net, Current USD 500,000 2023-09-30 2023 Q3 10-Q 2023-11-14 0000950170-23-063716
us-gaap RedeemableNoncontrollingInterestEquityPreferredCarryingAmount Redeemable Noncontrolling Interest, Equity, Preferred, Carrying Amount USD 143.81M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap RepaymentsOfShortTermDebt Repayments of Short-term Debt USD 5.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 18.16M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 0 2020-09-30 2020 Q3 10-Q 2020-11-12 0001564590-20-053571
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -527.77M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability Right-of-Use Asset Obtained in Exchange for Finance Lease Liability USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0001662774-25-000012
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 20.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap SeveranceCosts1 Severance Costs USD 500,000 2023-08-04 2024 FY 10-K 2025-03-24 0001662774-25-000012
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 15.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost Share-based Payment Arrangement, Accelerated Cost USD 100,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-24 0001662774-25-000012
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage pure 0.5 2023-08-04 2024 FY 10-K 2025-03-24 0001662774-25-000012
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 114,437 2018-07-15 2018-07-16 2020 Q3 10-Q 2020-11-12 0001564590-20-053571
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsShareBasedLiabilitiesPaid Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Share-based Liabilities Paid USD 3.60M 2022-01-01 2022-03-31 2022 Q3 10-Q 2022-11-09 0000950170-22-023877
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.802 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-16 0001564590-20-011165
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.019 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-16 0001564590-20-011165
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 0.82 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0000950170-24-039440
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 275,000 2022-02-28 2022 Q2 10-Q 2022-08-09 0000950170-22-016102
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 300,000 2023-12-31 2023 FY 10-K 2024-04-01 0000950170-24-039440
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 11.10M 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0000950170-24-039440
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value USD/shares 2.35 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-16 0001564590-20-011165
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost Share-based Payment Arrangement, Plan Modification, Incremental Cost USD 2.12M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-15 0000950170-23-008148
us-gaap SharePrice Share Price USD/shares 0.989 2023-10-20 2024 FY 10-K 2025-03-24 0001662774-25-000012
us-gaap ShortTermInvestments Short-term Investments USD 65.42M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 96,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0000950170-24-039440
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -65.70M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.368 2019-04-25 2020 Q2 10-Q 2020-08-14 0001564590-20-040300
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 1,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 104.99M 2019-01-01 2019-12-31 2021 FY 10-K 2022-03-01 0000950170-22-002571
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 183,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-11 0000950170-25-106535
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures Stock Issued During Period, Value, Restricted Stock Award, Forfeitures USD 18,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-24 0001662774-25-000012
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 340,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap SupplementalUnemploymentBenefitsSeveranceBenefits Supplemental Unemployment Benefits, Severance Benefits USD 1.90M 2022-03-31 2022 Q1 10-Q 2022-05-10 0000950170-22-009040
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 294,370 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 211,301.868 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 211,301.868 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap TradingSecurities Debt Securities, Trading, and Equity Securities, FV-NI USD 86.23M 2023-03-31 2023 Q1 10-Q 2023-05-15 0000950170-23-022241
us-gaap TranslationAdjustmentFunctionalToReportingCurrencyGainLossReclassifiedToEarningsNetOfTax Translation Adjustment Functional to Reporting Currency, Gain (Loss), Reclassified to Earnings, Net of Tax USD 5.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic Undistributed Earnings (Loss) Allocated to Participating Securities, Basic USD 3.12M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-11 0001193125-26-217098
us-gaap UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted USD 3.10M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-11 0001193125-26-217098
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 35.88M 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 37,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 31.51M 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0001662774-25-000012
us-gaap UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations USD 24,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 500,000 2023-12-31 2023 FY 10-K 2024-04-01 0000950170-24-039440
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD -6.40M 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-10 0001193125-26-151364
us-gaap ValueAddedTaxReceivable Value Added Tax Receivable USD 6.76M 2025-09-30 2025 Q3 10-Q 2025-11-12 0001193125-25-277529
us-gaap ValueAddedTaxReceivableCurrent Value Added Tax Receivable, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap ValueAddedTaxReceivableNoncurrent Value Added Tax Receivable, Noncurrent USD 0 2026-06-30 2026 Q2 10-Q 2026-08-14 0001193125-26-352201
us-gaap WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount USD 6.36M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-11 0001193125-26-217098
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 694,000 2026-03-31 2026 Q1 10-Q 2026-05-11 0001193125-26-217098
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 6.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 30.13M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-10 0000950170-22-009040
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 6.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460562

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →